Page 23 - Epic Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epic Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epic Sciences Today - Breaking & Trending Today

Global Liquid Biopsy Markets Report 2021-2025 - Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms

Published: February 4, 2021

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Impact of NGS on pricing 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Liquid Biopsy Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Liquid Biopsy NGS Panels - Diverse Test Claims CMS Colon Cancer Screening Memo Bodes Well for Assays Natera Liquid Biopsy Test Coverage to Expand Freenome Closes Financing to...

Source: prnewswire.com

Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic

Published: February 2, 2021

Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic February 02, 2021 04:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com's offering. The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitoring. The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Poten...

Source: globenewswire.com

Global Immuno-Oncology Diagnostics Markets, 2021-2025: Checkpoint Assays, Cytokine Assays, Genomic Germline, Genomic Tumour, Tumor Microenviroment

Published: January 29, 2021

4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Qiagen Expands Immuno-Oncology Portfolio IncellDx Awarded PD-L1 Detection Patent FDA Approves CDx for Trastuzumab Promega Nabs CE Mark for Microsatellite Instability IVD ArcherDx partners with AstraZeneca for Immuno-Oncology Germline Results Guides Precision Therapy ...

Source: prnewswire.com